Tag: TCAR

Charing Cross audience as-yet unconvinced by data supporting transcarotid artery revascularisation

Audience polling during the Acute Stroke Challenges session at this year’s Charing Cross Symposium (CX 2022; 26–28 April, London, UK and virtual) revealed scepticism...

Silk Road Medical announces FDA approval of expanded indications for the...

Silk Road Medical recently announced that the US Food and Drug Administration (FDA) approved expanded indications for the company's Enroute stent to include patients...

Worldwide TCAR analysis provides “roadmap” to evaluate future training approaches

An analysis of the worldwide experience of transcarotid artery revascularisation (TCAR) has produced key objective proficiency metrics and an analytic framework to assess adequate...

Expedited carotid artery surgery after index event “probably safer” than expedited...

A systematic review and meta-analysis of 71 studies suggests that, at present, carotid endarterectomy (CEA) is safer than carotid artery stenting (CAS) when performed...
tcar restenotic carotid lesions

Cost-effectiveness of TCAR versus carotid endarterectomy addressed in new study

A cost-effectiveness model based on peer-reviewed sources suggests that, although five-year costs for transcarotid artery revascularisation (TCAR; Silk Road Medical) were higher than those for...

TCAR yields “high technical success, with an extraordinarily low stroke and...

Outcomes in a cohort of patients who consented to one year of follow-up after transcarotid revascularisation (TCAR; Silk Road Medical) treatment for carotid stenosis...

Study detects no difference in adverse outcomes from balloon dilatation strategy...

Avoiding a strategy of post-stent balloon dilation during transcarotid artery revascularisation (TCAR) may be unnecessary—a “contradistinction” to results shown in conventional transfemoral carotid artery...
tcar restenotic carotid lesions

TCAR may be associated with favourable outcomes for treatment of restenotic...

Transcarotid artery revascularisation (TCAR; Silk Road Medical) may be associated with favourable in-hospital outcomes for the treatment of restenotic carotid lesions after carotid endarterectomy...

First ever analysis of TCAR in standard surgical risk patients demonstrates...

Silk Road Medical has announced positive results from an independent analysis of standard surgical risk patients undergoing carotid endarterectomy (CEA) and transcarotid artery revascularisation...
carotid disease stenting

Treatment of asymptomatic carotid bifurcation occlusive disease and potential role of...

Peter A Schneider (San Francisco, USA) discusses the role stenting can play, alongside the existing best medical therapy, in treating asymptomatic carotid disease patients. Best...

Study finds hospital availability of TCAR associated with an improvement in...

Silk Road Medical has announced positive results from a comparative-effectiveness study have been published in JAMA Network Open. The study found the availability of TCAR...